Analysis of Renal Function & Injury---NGAL
Views：1644 Add time：2018-11-20 11:27:21
Neutrophil gelatinase-associated lipocalin (NGAL) is a novel early marker of acute kidney injury (AKI) for which it has been shown that it can also be released from the injured myocardium. It is a small protein expressed in neutrophils and in low levels in the kidney, prostate, and epithelia of the respiratory and alimentary tracts.
Under normal conditions NGAL levels are low in urine and plasma but rise sharply within 2 hours from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any significant rise in serum creatinine.
Because NGAL is protease resistant and small, the protein is easily excreted and detected in the urine. NGAL levels in patients with AKI have been associated with the severity of their prognosis and can be used as a biomarker for AKI. NGAL can also be used as an early diagnosis for procedures such aschronic kidney disease, contrast induced nephropathy, and kidney transplant.
Anti-HumanNGAL Monoclonal Antibodies
A newgenerationof anti-NGALmonoclonal antibodies, which was recently produced by CUSAg,makes possible the development of highly sensitive immunoassays. CUSAg antibodies areevaluatedon different types of platforms e.g.CLIA, latex-enhancedimmunoturbidimetry (LETIA),lateral flow, andmagnetic particles.
I. CLIA platform
All monoclonal antibodies were tested in pairs as capture and detection antibodies to select the best two-site MAb combinations for the development of a quantitative sandwich immunoassay. Calibration curves for several best two-site combinations are shown in Fig 1(R2 >0.99). The best selected MAb combinations for quantification of human NGAL are (capture-detection respectively):
MAb combination A: CSB-DA001DmN①- CSB-DA001AmN①
MAb combination B: CSB-DA001AmN①- CSB-DA001DmN①
MAb combination C: CSB-DA001AmN②- CSB-DA001DmN①
MAb combination D: CSB-DA001AmN③- CSB-DA001DmN①
Fig.1 Calibration curves for NGAL in sandwich chemiluminescence immunoassay (CLIA)
II. LETIA platform
Anti-human NGAL monoclonal antibodieswere also evaluated via CUSAg latex-enhanced immunoturbidimetric assay. A set of NGAL calibratorsreacts with specific antibodies coated onto microparticles to form an insoluble complex which can be measured turbidimetrically at a series of different wavelengths (Fig.2).
Fig.2 Calibration curve for human NGALinlatex-enhanced immunoturbidimetric assay
I.A study was performed where 50 specimens were tested using different antibody combinations (A, B, C and D) on the CUSAg CLIA platform and compared to a high-quality comparison assay. Data from this study were analyzed and summarized in the following figure (Fig.3). Results showed the four combinations have correlation coefficients (r)> 0.90.
Fig.3 Determination of clinical samples using four MAb combinations on CLIA platform
II. In order to meet the application of CUSAg anti-NGAL MAbs on LETIA platform, 40clinical blood samples were separately tested using mixed MAbs on the CUSAg LETIA platform and compared to a commercial diagnostic kit. The correlation coefficient between the two systems is over 0.90.
Fig.4 Comparison ofCUSAg NGAL LETIA andcommercial diagnostic assays
Our anti-human NGAL monoclonal antibodies presented in PBS buffer without anypreservative were stored at -20°C, 2-8°C and 37°C for 15 days, respectively. During thisperiod,the titers of four MAbs weredetermined per 3 days, respectively. Fig.5 shows the relative titers of the MAbs treated at -20°C or 2-8°C were similar with that at 37°C. All the MAbs werestable from-20°C to 37°C.
Fig.5 Evaluation of the relative titers of four anti-NGAL MAbs stored at different temperature
Anti-HumanNGAL Polyclonal Antibody
Anti-human NGAL polyclonal antibody has been developed by CUSAg for more than 5 years,and it was characterized indetail during this time. Theantibodies are widely used in commercial NGAL immunoassay. In addition, the antibodies are used in research applications such as Western blotting, immunohistochemistry and many others.
NGAL antigens specifically react with anti-human NGAL polyclonal antibodies which were precoated onlatex beads, resulting in agglutination and increase in turbidity. The calibration curve was fitted according to the relationship between absorbance values and NGAL concentrations (Fig.1).
Fig.1.Calibration curve inparticle-enhanced turbidimetric immunoassay
Anti-Human NGAL polyclonal antibody was evaluated in medium-scale clinical tries with random blood samples from donate (n=50). Fig.2 showed that the correlation coefficient(r) is 0.98 between in-house latex reagents using CUSAg NGAL polyclonal antibodies and commercial NGAL immunoassay. These results show good agreement between the two systems.
Fig.2 Clinical comparisonbetween in-house latex reagentsand commercial NGAL immunoassay.
Stability ofPolyclonal Antibody
Anti-human NGALpolyclonal antibodies presented in PBS buffer without anypreservative were stored at 37°C and 4°C for 7 days, respectively. And then the antibodies were prepared into latex reagents and used to detect NGAL antigens. Table 1 revealed thedetection performanceofpolyclonal antibodies exposed at 37°C had no significant change compared to that at 4°C. These results showed that the antibody was thermostable.
Table 1 Comparison of detection performances of anti-human NGALpolyclonal antibodiesat37°C and 4°C for 7 days
A certain amount of excellent NGAL protein (Cat:CSB-DP001A) is also offered by CUSAg. It could be used as calibrator in immunoassay and applied on Western Blotting.
1. Rocha PN, Macedo MN, Kobayashi CD, et al.Role ofUrineNeutrophil Gelatinase-Associated Lipocalin (NGAL) in the Early Diagnosis of Amphotericin B-induced Acute Kidney Injury. Antimicrob Agents Chemother. 2015 Aug 24.
2. Quintavalle C, Anselmi CV, De Micco F, et al.Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury. Circ Cardiovasc Interv. 2015 Sep: 8(9).